Operator of a digital pharmacy platform intended to facilitate the delivery of prescription medication.
Operator of a digital pharmacy platform intended to facilitate the delivery of prescription medication.
Specialty Retail📍 New York, NYFounded 2015
Current Valuation
$1.2B
as of 2021-Q2
UNICORN
QL Price
$1.2B
0% vs last round
QuantLogix's current estimate for Capsule, published 2026-09-08 — in line with the last disclosed round of $1.2B (2021-Q2).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$1.2B
2021-Q2
weight 0.03
How this price has held up
No round has priced for Capsule since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-08 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Capsule, 2026-09-08 (8c8ea8a13290aae2).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Capsule going public?
No. Capsule is private and has not filed to go public. There is no S-1 on file.
What is Capsule's valuation in 2026?
Capsule is valued at $1.2B as of 2021-Q2, set by its Series D ($300M, Apr 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Capsule filed an S-1?
No public S-1 is on file for Capsule.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2015
HQ
New York, NY
Employees
851
Total Raised
$590M
Last Round
Series D — $300M (Apr 2021)
IPO Status
private
Fundraising Status
Series D · $300M · 5y 5mo ago
privateTotal raised $590M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series D
$300M
Apr 2021
—
$1.2B
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Capsule — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-03. Re-checked weekly.
Talent Signal
Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
9
via ashby
Product-build share
33%
engineering, research, product, design
Trajectory
steady
balanced build + GTM — 33% builders vs 67% go-to-market/G&A — scaling both sides.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Frontend EngineerAI EngineerLead Product DesignerAccount Executive, Strategic AccountsSales Development Representative Head of Demand Generation
Counted from Capsule's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CarePharmaceuticalRetail
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q2. Refreshed quarterly.